title: Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.
abstract: The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Jin
authors.initials: J
authors.lastname: Lu
authors.affiliation: b Shanghai Changzheng Hospital , Shanghai , China ;
authors.forename: Jian
authors.initials: J
authors.lastname: Hou
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Kai-Yan
authors.initials: KY
authors.lastname: Liu
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Simrit
authors.initials: S
authors.lastname: Parmar
authors.affiliation: d MD Anderson Cancer Center , Madrid , Spain ;
authors.forename: Adolfo
authors.initials: A
authors.lastname: De La Fuente
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Börje
authors.initials: B
authors.lastname: Andersson
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: ChenHua
authors.initials: C
authors.lastname: Yan
authors.affiliation: e Peking Union Medical College Hospital , Beijing , China ;
authors.forename: Daobin
authors.initials: D
authors.lastname: Zhou
authors.affiliation: f Singapore General Hospital, Singapore , Singapore ;
authors.forename: Daryl
authors.initials: D
authors.lastname: Tan
authors.affiliation: g Royal Melbourne Hospital , Melbourne , Australia ;
authors.forename: David
authors.initials: D
authors.lastname: Ritchie
authors.affiliation: h First Affiliated Hospital of Soochow University , Jiangsu , China , Jiangsu Institute of Hematology ;
authors.forename: Deipei
authors.initials: D
authors.lastname: Wu
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Shpall
authors.affiliation: i Stanford University , Palo Alto , CA , USA ;
authors.forename: Ginna G
authors.initials: GG
authors.lastname: Laport
authors.affiliation: j First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital , Nanjing , China ;
authors.forename: JianYong
authors.initials: J
authors.lastname: Li
authors.affiliation: k Ruijin Hospital , Shanghai , China ;
authors.forename: Jiong
authors.initials: J
authors.lastname: Hu
authors.affiliation: l Gansu Provincial Key Laboratory of Hematology , Lanzhou , China ;
authors.forename: Lian Sheng
authors.initials: LS
authors.lastname: Zhang
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
authors.affiliation: m Post Graduate Institute of Medical Education and Research , Chandigarh , India ;
authors.forename: Pankaj
authors.initials: P
authors.lastname: Malhotra
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Qian
authors.initials: Q
authors.lastname: Jiang
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Yazhen
authors.initials: Y
authors.lastname: Qin
authors.affiliation: n Prince of Wales Hospital, the Chinese University of Hong Kong , Hong Kong, China ;
authors.forename: Raymond
authors.initials: R
authors.lastname: Wong
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Richard
authors.initials: R
authors.lastname: Champlin
authors.affiliation: o Faculty of Medicine Siriraj Hospital , Bangkok , Thailand ;
authors.forename: Surapol
authors.initials: S
authors.lastname: Issaragrisil
authors.affiliation: p Methodist Hospital , Houston , TX , USA ;
authors.forename: Swaminathan
authors.initials: S
authors.lastname: Iyer
authors.affiliation: q Christian Medical College and Hospital , Vellore , India ;
authors.forename: Vikram
authors.initials: V
authors.lastname: Mathews
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
authors.affiliation: r Wuhan Union Hospital , Wuhan , China ;
authors.forename: Yu
authors.initials: Y
authors.lastname: Hu
authors.affiliation: s Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences , Tianjin , China ;
authors.forename: Zhijian
authors.initials: Z
authors.lastname: Xiao
authors.affiliation: t General Hospital of Tianjin Medical University , Tianjin , China ;
authors.forename: Zonghong
authors.initials: Z
authors.lastname: Shao
authors.affiliation: u Baylor College of Medicine , Houston , TX , USA ;|v MDRing , Houston , TX , USA ;
authors.forename: Rafael
authors.initials: R
authors.lastname: Rosengarten
authors.affiliation: v MDRing , Houston , TX , USA ;|w Johns Hopkins Medical Institute , Baltimore, MD , USA ;
authors.forename: Jon
authors.initials: J
authors.lastname: Steuernagle
authors.affiliation: a Peking University People's Hospital, Peking University Institute of Hematology , Beijing , China ;
authors.forename: Jun Huang
authors.initials: JH
authors.lastname: Xiao
authors.affiliation: c Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA ;
authors.forename: Robert
authors.initials: R
authors.lastname: Orlowski
authors.affiliation: x Queen Mary Hospital , Hong Kong.
authors.forename: Chor Sang
authors.initials: CS
authors.lastname: Chim
mesh_terms: D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000628:therapy*
keywords: APHCON; China; MDRing; Myeloma; survey